secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001641172-25-011452
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Abeona Therapeutics holds annual meeting; elects three Class 3 directors
------------------------------------------------------------------------

- Mark J. Alvino, Faith L. Charles, and Donald A. Wuchterl elected as Class 3 directors.
- Alvino received 26,260,868 votes for, Charles 26,774,705, Wuchterl 26,856,990.
- Advisory vote on NEO compensation approved: 25,777,223 for, 1,552,881 against.
- Ratification of Deloitte & Touche as auditor for FY 2025 approved: 34,334,516 for.
- All proposals passed with broker non-votes on director election and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000164117225011452/0001641172-25-011452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000164117225011452/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer